How to understand the key facts and figures about rare cancer research.

Rare cancers are a loose cluster of cancers with one unifying characteristic: they associate degree effect on} little range of people. These cancers typically begin in an uncommon place within the body or are subtypes of a lot of common cancers that behave otherwise and thus need special treatment. There are presently no reliable statistics on the numbers of Canadians diagnosed with rare cancers.

Rare cancers have distinct characteristics that create them fascinating to study. However, the study of rare cancers tends to be underfunded.

Today, poor understanding of the fundamental biology of rare cancers, high-mortality rates and ineffective treatments make these diseases a pressing health issue in Canada.

Our analysis Strategy

Given these challenges, the Terry Fox analysis Institute has launched into a multi-pronged strategy to fund the most effective rare cancer scientific groups and programs within the country.

In 2021/22, roughly 5.9 per cent of the money endowed by the TFRI supported research into rare cancers. This additional up to a complete investment of $600,000.*

To apportion its resources, the Institute has international specialists appraise the excellence and also the potential for impact of all its research projects. This approach distinguishes our research investment strategy from all others in North American nation and permits donors to be assured that their investment is supporting the highest 5% of Canadian researchers and their science.


 

Comments

Popular posts from this blog

Can genome sequencing be used to predict disease?

Why are Drug Prices for Rare Diseases on the Rise?

5 Facts You May Not Know About Gynaecologic Cancer